O Romeo Hits ₹91 Crore
Shahid Kapoor's "O Romeo" earned ₹91 crore worldwide after 11 days in theaters, though the film slowed on its second Monday. AMC Theatres is rolling out a new policy to reserve "best seats" exclusively for VIP loyalty program members. Recent reviews highlight Tanmaya Shekhar's indie "NukkadNaatak" as a street-play coming-of-age tale and Tamil noir "AndhaNaal" as Rashomon-inspired.
- "O Romeo" was produced with a budget reportedly between ₹125-150 crore. Its domestic net collection after 11 days was approximately ₹57.45 crore. - The AMC Theatres "Sightline" pricing initiative, which charged more for seats in the middle of the theater, was discontinued after a pilot program. The company stated the decision was to ensure its ticket prices remained competitive, as other theater chains did not adopt similar models. - Tanmaya Shekhar's "NukkadNaatak" is a coming-of-age story about two college students who are expelled and, as a community service project, must educate children from a nearby slum. The film, inspired by the director's personal experiences, is set for release on February 27, 2026. - The 1954 film "AndhaNaal" is considered the first film noir in Tamil cinema and was notable for having no songs, dance, or stunt sequences. The plot revolves around the investigation into the murder of a radio engineer, with each suspect's account revealing new possibilities. - "O Romeo" is Shahid Kapoor's seventh highest-grossing film and marks his reunion with director Vishal Bhardwaj. - The AMC "Sightline" policy was criticized by some, including actor Elijah Wood, for penalizing people with lower incomes. The company is now exploring offering spacious, reclining front-row seats. - "NukkadNaatak" was funded through personal and community support and marks the feature film debut for the director, actors, music director, and cinematographer. - "AndhaNaal" was inspired by Akira Kurosawa's 1950 film "Rashomon" and is set against the backdrop of the Japanese bombing of Madras (now Chennai) during World War II.